New in MMWR: Use of Tecovirimat for Treatment of Monkeypox

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

MMWR Early Release – Vol. 71, September 9, 2022

September 9, 2022

EARLY RELEASE

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022

MMWR Weekly Briefing Podcast: Week of August 15

 

The latest MMWR Weekly Briefing is live. This episode covers three reports, including reports highlighting paralytic polio in an unvaccinated person in New York, object and surface contamination in a household of people with monkeypox and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |